BILLERICA, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the formation of the RainDance HemOnc Consortium, composed of a select group of hematologic clinical research experts drawn from prominent comprehensive cancer centers in the U.S. and Europe. Members of the consortium will present first data on a new ThunderBolts Myeloid Panel using next-generation sequencing (NGS) during the American Society of Hematology (ASH) Annual Meeting in San Francisco on December 6-9, 2014.
Help employers find you! Check out all the jobs and post your resume.
